19 November 2017
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics evaluates the performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.
Several steatosis biomarkers are available with limited independent validation.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors